por
Bradley, Benjamin T.,
Bryan, Andrew,
Fink, Susan L.,
Goecker, Erin A.,
Roychoudhury, Pavitra,
Huang, Meei-Li,
Zhu, Haiying,
Chaudhary, Anu,
Madarampalli, Bhanupriya,
Lu, Joyce Y. C.,
Strand, Kathy,
Whimbey, Estella,
Bryson-Cahn, Chloe,
Schippers, Adrienne,
Mani, Nandita S.,
Pepper, Gregory,
Jerome, Keith R.,
Morishima, Chihiro,
Coombs, Robert W.,
Wener, Mark,
Cohen, Seth,
Greninger, Alexander L.
Publicado 2021
“…Here, we investigated the performance characteristics of the recently FDA-authorized semiquantitative anti-spike protein AdviseDx SARS-CoV-2 IgG II assay compared to the FDA-authorized anti-nucleocapsid protein Abbott
Architect SARS-CoV-2 IgG, Roche Elecsys anti-SARS-CoV-2-S, EuroImmun anti-SARS-CoV-2 enzyme-linked immunosorbent assay (ELISA), and GenScript surrogate virus neutralization assays and examined the humoral response associated with vaccination, natural protection, and vaccine breakthrough infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto